Dysregulation of UBASH3B has been implicated in enhancing EGFR-mediated oncogenic signaling, suggesting a plausible role underlying the aggressive phenotype and poor clinical outcomes associated with HNSCC. Here, UBASH3B is linked to head and neck squamous cell carcinoma.